Literature DB >> 22307919

Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry.

Jianguang Ji1, Kristina Sundquist, Jan Sundquist, Kari Hemminki.   

Abstract

Registry-based cancer incidence and mortality data are widely used for etiologic research, cancer control and health care monitoring and planning. The complete coverage of all cases is the key criteria of data quality but it is difficult to assess because the alternative sources of data may be flawed. The aim of our study was to examine, at a nationwide level, the completeness of the Swedish Cancer Registry (CR) regarding persons who died of cancer, based on the Cause of Death Registry (DR), and using the Hospital Discharge Registry (HDR) as an additional source of data. Individuals who died of cancer from years 1999 through 2008 recorded in DR were linked to CR and HDR. A total of 190,692 individuals were identified from DR with cancer as the underlying cause of death; the mean identification rate of concordant cancer in CR was 79.8%, depending on tumor site and age at death. Breast, bladder and prostate cancers showed the highest rate of identification, whereas bone, liver and pancreatic cancers showed the lowest rate of identification. CR had no records on 10.6% of cancer cases recorded in DR. Similarly, the identification rate in HDR was 84.5% for concordant cancer and with 9.6% of cases missing. Neither source reported cancers for 3.4% of cancer cases recorded in DR. In conclusion, some 10% of cancer deaths had no cancer records in CR or in HDR, and 3.4% were missing in both sources. The identification rate depended on tumor site, age at death and, to some extent, death outside hospital.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 22307919     DOI: 10.1002/ijc.27462

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  41 in total

1.  Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2018-07-10       Impact factor: 22.113

2.  Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2019-08-08       Impact factor: 22.113

3.  Improving Central Cancer Registry Surveillance through Interstate Data Exchange of Electronic Pathology Reports.

Authors:  Morgan M Millar; Valerie Yoder; Denise Jozwik; Julia Espinoza; Debbi Lemons; Carol Y Jewell; Carol Sweeney
Journal:  J Registry Manag       Date:  2021

4.  Is Neighbourhood Linking Social Capital Associated With Colorectal Cancer Incidence and Mortality? A National Cohort Study From Sweden.

Authors:  Tsuyoshi Hamano; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Prim Prev       Date:  2021-07-16

5.  [Diagnosis of and therapy for hepatocellular carcinoma].

Authors:  T F Greten; N P Malek; S Schmidt; J Arends; P Bartenstein; W Bechstein; T Bernatik; M Bitzer; A Chavan; M Dollinger; D Domagk; O Drognitz; M Düx; S Farkas; G Folprecht; P Galle; M Geißler; G Gerken; D Habermehl; T Helmberger; K Herfarth; R T Hoffmann; M Holtmann; P Huppert; T Jakobs; M Keller; J Klempnauer; F Kolligs; J Körber; H Lang; F Lehner; F Lordick; A Lubienski; M P Manns; A Mahnken; M Möhler; C Mönch; P Neuhaus; C Niederau; M Ocker; G Otto; P Pereira; G Pott; J Riemer; K Ringe; U Ritterbusch; E Rummeny; P Schirmacher; H J Schlitt; K Schlottmann; V Schmitz; A Schuler; H Schulze-Bergkamen; D von Schweinitz; D Seehofer; H Sitter; C P Straßburg; C Stroszczynski; D Strobel; A Tannapfel; J Trojan; I van Thiel; A Vogel; F Wacker; H Wedemeyer; H Wege; A Weinmann; C Wittekind; B Wörmann; C J Zech
Journal:  Z Gastroenterol       Date:  2013-11-15       Impact factor: 2.000

6.  Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site.

Authors:  Matias Riihimäki; Akseli Hemminki; Kristina Sundquist; Kari Hemminki
Journal:  BMC Cancer       Date:  2014-06-14       Impact factor: 4.430

7.  Survival in colon and rectal cancers in Finland and Sweden through 50 years.

Authors:  Kari Hemminki; Asta Försti; Akseli Hemminki
Journal:  BMJ Open Gastroenterol       Date:  2021-07

8.  Data coverage of a cancer registry in southern Iran before and after implementation of a population-based reporting system: a 10-year trend study.

Authors:  Kamran Bagheri Lankarani; Zahra Khosravizadegan; Abbas Rezaianzadeh; Behnam Honarvar; Mohsen Moghadami; Hossein Faramarzi; Mojtaba Mahmoodi; Mahin Farahmand; Seyed Masoom Masoompour; Bahman Nazemzadegan
Journal:  BMC Health Serv Res       Date:  2013-05-06       Impact factor: 2.655

9.  Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.

Authors:  Kari Hemminki; Nicholas Pavlidis; Konstantinos K Tsilidis; Kristina Sundquist; Jianguang Ji
Journal:  Sci Rep       Date:  2016-03-24       Impact factor: 4.379

10.  Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers.

Authors:  Guoqiao Zheng; Kristina Sundquist; Jan Sundquist; Tianhui Chen; Asta Försti; Otto Hemminki; Kari Hemminki
Journal:  Eur Urol Open Sci       Date:  2021-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.